Medicación estimulante para el TDAH en el entorno escolar: Metilfenidato 30/70

  1. Antonio Pelaz 1
  2. María Jesús Mardomingo 2
  3. Oscar Herreros 3
  4. Pedro Javier Rodríguez Hernández 4
  5. Xavier Gastaminza 5
  6. Antonio Manuel Muñoz 6
  7. Sylvia Plaza 6
  1. 1 Hospital Clínico (Madrid)
  2. 2 Hospital Universitario Gregorio Marañón (Madrid)
  3. 3 Hospital Universitario Virgen de las Nieves (Granada)
  4. 4 Hospital de Día Infan-til y Juvenil “Diego Matías Guigou y Costa”. Servicio de Psiquiatría. Hospital Universitario Ntra. Sra. de Candelaria. Tenerife
  5. 5 Hospital Vall d’Hebron (Barcelona)
  6. 6 Departamento Médico, Shire Pharmaceuticals
Montrer des affiliations +
Revue:
Revista de Psiquiatría Infanto-Juvenil

ISSN: 2660-7271,  1130-9512

Année de publication: 2013

Volumen: 30

Número: 1

Pages: 16-26

Type: Article

DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Revista de Psiquiatría Infanto-Juvenil

Résumé

Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common psychiatric disorders in child-hood, with an overall accumulated prevalence around 5%. It is characterized by the presence of symptoms such as inattention, impulsivity and hyperactivity. Children with ADHD show difficulties from an early age in focus-ing attention, control of impulsiveness and modulation of behavior. Clinical evidence suggests that, unless they reach a minimum of social competence at 8 years of age, these children will have a high probability of having so-cial difficulties throughout his life. Treatment of ADHD consists of several strategies combined (multimodal treatment), where pharmacotherapy is prominent under different clinical practice guidelines. In the school envi-ronment, the goals of ADHD treatment focus on child ad aptation to social and academic requirements by reduc-ing the impact of core symptoms. Methylphenidate has proved effective with an adequate safety profile. Their release profile is correlated with the clinical efficacy and hence a release profile uniformly covering the 8 school hours as methylphenidate 30/70 is effective throughout the school day.

Références bibliographiques

  • Polanczyk, de Lima, Horta, Biederman, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164 (6): 942-8.
  • American Psychiatric Association [DSM-IV-TR], 2000.
  • CIE-10: ICD-10 copyright © 1992 by World Health Organization.
  • A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. MTA cooperative Group. Arch. Gen Psychiatry 1999: 1088-1096.
  • Barkley, R. A. (2006). Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment (3rd ed.).
  • Guilford Press, Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998; 279: 1100–1107.
  • Cardo E, Servera M, Llobera J. Estimation of the prevalence of attention defi cit hyperactivity disorder among the standard population on the island of Majorca. Rev Neurol. 2007 1; 44 (1): 10-4.
  • Benjumea P, Mojarro MA. Trastornos hipercinéticos: estudio epidemiológico en doble fase de una población sevillana. Anales de Psiquiatría. 1993; 9 (7): 306-11.
  • Scheffler RM, Brown TT, Fulton BD, Hinshaw SP, Levine P, Stone S. Positive Association Between Attention-Deficit/ Hyperactivity Disorder Medication Use and Academic Achievement During Elementary School. Pediatrics 2009; 123: 1273.
  • Guía de Práctica Clínica sobre el Trastorno por Déficit de Atención con Hiperactividad (TDAH) en Niños y Adolescentes. Ministerio Sanidad, Política Social e Igualdad. 2010.
  • National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder. Diagnosis and management of ADHD in children, young people and adults. Great Britain: The British Psychological Society and The Royal College of Psychiatrist; 2009.
  • Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME. Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry 1997; 36:1222–1227.
  • CHILD MENTAL HEALTH AND HUMAN CAPITAL ACCUMULATION: THE CASE OF ADHD Janet Currie Mark Stabile http://www.nber.org/papers/w10435.
  • McGee, R. Williams, S. Feehan, M. Attention deficit disorder and age of onset of problem behaviors. Journal of Abnormal Child Psychology 1992; 20: 487–502.
  • McGee, R., Prior, M., Williams, S. The long-term significance of teacher-rated hyperactivity and reading ability in childhood: findings from two longitudinal studies. The Journal of Child Psychology and Psychiatry 2002; 43: 1004–1017.
  • School Functioning of Students With ADHD: Du-Paul School Psychology Review,2007, Volume 36, No. 2, pp. 183–194.
  • Blair, C.,Diamond, A.. Biological processes in prevention and intervention: The promotion of selfregulation as a means of preventing school failure. Development and Psychopathology (2008), 20(3), 899-911.
  • Duncan, G. J., Dowsett, C. J., Claessens, A., Magnuson, K., Huston, A. C., Klebanov, P., et al. (2007). School readiness and later achievement. Dev Psychol, 43(6), 1428-1446.)
  • Loe, I.M.,Feldman, H.M. Academic and educational outcomes of children with ADHD. J Pediatr Psychol. 2007 Jul;32(6):643-54. Epub 2007 Jun 14
  • Barry, R. J., Clarke, A. R., McCarthy, R., Selikowitz, M. EEG coherence in attention-deficit/ hyperactivity disorder: a comparative study of two DSM-IV types. Clin Neurophysiol, (2002);113(4), 579-585.,
  • Biederman, J., Faraone, S., Milberger, S., Guite, J., Mick, E., Chen, L., et al. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 1996., 53(5), 437-46)
  • Barkley, R.A., Fischer, M, Edelbrock, C.S., & Smallish, L. (1990). The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry. Jul;29(4):546-57)
  • Mannuzza, S., Klein, R.G., Bessler, A., Malloy, P. LaPadula, M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry, 1993; 50(7), 565-76.)
  • Hinshaw, S.P. (1992). Academic underachievement, attention deficits, and aggression: comorbidity and implications for intervention. J Consult Clin Psychol, 60(6), 893-903.
  • Rapport, M.D, Scanlan, S.W., Denney, C.B. Attention-deficit/hyperactivity disorder and scholastic achievement: a model of dual developmental pathways. J Child Psychol Psychiatry, 1999; 40(8), 1169-1183).
  • Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M. Cost-Effectiveness of ADHD Treatments: Findings from the Multimodal Treatment Study of Children With ADHD. Am J Psychiatry 2005; 162: 1628-1636.
  • Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ: Modifiers of long term school outcomes for children with Attention- deficit/Hyperactivity Disorder: Does treatment with stimulant medication make a difference? Results from a population- based study. J Develop Behav Pediatr 2007; 28: 274–287.
  • Powers RL, Marks DJ, Miller CJ, Newcorn JH, Halperin JM. Stimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder Moderates Adolescent Academic Outcome. J Child Adolesc Psychopharmacol. 2008; 18 (5): 449-59.
  • Zoëga H, Rothman KJ, Huybrechts KF, Ólafsson Ö, Baldursson G, Almarsdóttir AB et al. A Population- Based Study of Stimulant Drug Treatment of ADHD and Academic Progress in Children. Pediatrics. 2012; 130 (1): e53-62.
  • Loe IM, Feldman HM. Academic and Educational Outcomes of Children With ADHD. J Pediatr Psychol. 2007; 32 (6): 643-54.
  • Evans SW, Pelham WE, Smith BH, Bukstein O, Gnagy EM. Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD. Exp Clin Psychopharmacol. 2001; 9 (2): 163-75.
  • Richard M. Scheffler, Timothy T. Brown, Brent D. Fulton, Stephen P. Hinshaw, Peter Levine, Susan Stone. Positive Association Between Attention-Deficit/Hyperactivity Disorder Medication Use and Academic Achievement During Elementary School. Pediatrics. 2009; 123 (5): 1273-9.
  • Blader JC, Pliszka SR, Jensen PS, Schooler NR, Kafantaris V. Blader et al. Stimulant-Responsive and Stimulant-Refractory Aggressive Behavior Among Children With ADHD. Pediatrics 2010; 126: e796.
  • Gadow KD, Nolan E, Sprafkin J, Sverd J. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment. J Dev Behav Pediatr. 1995; 16 (3): 167-76).
  • Gadow KD, Nolan EE, Sverd J, Sprafkin J, Paolicelli L. Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry. 1990; 29 (5): 710-8.
  • Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder— first upgrade. Eur Child Adolesc Psychiatry 2004; 13(Suppl1): 17–30.
  • NICE clinical guideline 72. Attention deficit hyperactivity disorder. www.nice.org.uk/CG072.
  • Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. American Journal of Psychiatry 2004; 161, 1173–1180.
  • Agencia Española del Medicamento y Producto Sanitario (AEMPS). http://www.aemps.gob.es/
  • Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J et al. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry. 2006; 15 (8): 476-95.
  • Wigal, Sanchez, DeCory, D’imperio, Swanson. Selection of the optimal doses ratio for a controlled-delivery formulation of methylphenidate. The journal of applied research 2003; 3 (1).
  • Findling RL, Quinn D, Hatch SJ, Cameron SJ, DeCory HH, McDowell M. Comparison of the clinical efficacy of twice-daily Ritalin and oncedaily Equasym XL with placebo in children with Attention Deficit/Hyperactivity Disorder. Eur Child Adolesc Psychiatry. 2006; 15 (8): 450-9.
  • M.A. González, H.S. Pentikis, N. Anderl, M.F. Ben e dict, H.H. DeCory, S.J. Hirshey Dirksen et al. Methylphenidate bioavailability from two extended-release formulations. Int J Clin Pharmacol Ther. 2002; 40 (4): 175-84.
  • Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J et al. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics. 2004; 113 (3 Pt 1): e206-16.
  • Rothenberger A, Döpfner M. Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherente. Eur Child Adolesc Psychiatry. 2011; 20 Suppl 2: S235-42.
La source de données: Dialnet